D
USANA Health Sciences, Inc. USNA
$27.27 -$0.28-1.02% NYSE
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
EPS (TTM)

06/28/2025 03/29/2025 12/28/2024 09/28/2024 06/29/2024
Net Income -38.06% -43.67% -34.11% -9.15% -13.12%
Total Depreciation and Amortization 50.33% 35.23% 8.99% 2.12% -1.07%
Total Amortization of Deferred Charges -- -- -- -- --
Total Other Non-Cash Items -37.31% -40.18% -32.66% -34.94% -21.77%
Change in Net Operating Assets 29.85% 42.87% 53.56% 52.04% -58.60%
Cash from Operations -14.76% -22.12% -13.66% -4.53% -19.62%
Capital Expenditure 17.88% 37.93% 30.50% -49.16% -16.45%
Sale of Property, Plant, and Equipment 1,120.00% 238.89% 326.67% 312.50% -70.59%
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities -181.18% -98.18% -89.82% -89.82% -89.82%
Cash from Investing -1,397.66% -1,580.99% -1,679.46% -92.49% -43.04%
Total Debt Issued 1,558.53% 1,013.52% 1,436.12% 97.47% 18.64%
Total Debt Repaid -1,566.06% -95.60% -95.60% -96.40% -18.08%
Issuance of Common Stock -- -- -- -- --
Repurchase of Common Stock -22.90% 39.74% 13.78% 13.46% -681.00%
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -- -- -- 100.00% 100.00%
Cash from Financing -24.47% 130.60% 167.10% 15.46% -604.23%
Foreign Exchange rate Adjustments 155.22% 76.56% -147.42% 277.18% 68.34%
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash -661.67% -554.30% -454.76% -2.59% -53.22%